Assenagon Asset Management
YARW

Assenagon Asset Management’s Yarrow Bioscience, Inc. Common Stock YARW Stock Holding History

Assenagon Asset Management’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-18
Closed -$388K – 1088
2019
Q2 		$388K Buy
+18
New +$445K ﹤0.01% 883

Other funds holding YARW

First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Assenagon Asset Management's YARW Position: Q3 2019 in Review

Assenagon Asset Management sold out of Yarrow Bioscience, Inc. Common Stock (YARW) in Q3 2019, closing a stake of 18 shares — an estimated $388K sold.

Assenagon Asset Management first reported a position in YARW in Q2 2019 and held it in 1 quarter. The position peaked at $388K in Q2 2019. 48 funds tracked by Wall St. Rank hold YARW as of Q3 2019.

  • Assenagon Asset Management reported no remaining Yarrow Bioscience, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Assenagon Asset Management sold 18 Yarrow Bioscience, Inc. Common Stock shares in Q3 2019, an estimated $388K.
  • Assenagon Asset Management first reported a position in Yarrow Bioscience, Inc. Common Stock in Q2 2019 and held it in 1 quarter.
  • Assenagon Asset Management's Yarrow Bioscience, Inc. Common Stock position peaked at $388K in Q2 2019.
  • 48 funds tracked by Wall St. Rank held Yarrow Bioscience, Inc. Common Stock as of Q3 2019.

Based on Assenagon Asset Management's 13F filing for Q3 2019, filed 16 Oct 2019.